FDA Panel Recommends Approval For Sanofi’s Dengue Vaccine Only For Younger People.

STAT (3/7, Branswell) reports a Food and Drug Administration advisory committee recommended approval for Sanofi’s dengue vaccine for people between the ages of 9 and 17, but not for adults. The panel recommended the vaccine only be used “by people who liv...